Quantitative liquid chromatography/mass spectrometry/mass spectrometry warfarin assay for in vitro cytochrome P450 studies

Analytical Biochemistry

Volumn 298, Issue 1, 2001, Pages 40-49

  Zhang, Zhi Yi ^a   King, Belinda M ^a   Wong, Y Nancy ^a  

^a EISAI RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; DISSOCIATION; DRUG INTERACTIONS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

COLLISION-ACTIVATED DISSOCIATIONS; DRUG-DRUG INTERACTIONS; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRIES; INTERNAL STANDARDS; LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY; MICROSOMAL PREPARATIONS; MULTIPLE REACTION MONITORING; PRODUCT ION SPECTRA;

METABOLITES;

CYTOCHROME P450; DRUG METABOLITE; WARFARIN;

APPARATUS; ARTICLE; ASSAY; CONCENTRATION (PARAMETERS); DISSOCIATION; ENZYME ACTIVITY; EVALUATION; HUMAN; HUMAN CELL; IONIZATION; LIQUID CHROMATOGRAPHY; LIVER CELL; LIVER MICROSOME; MASS SPECTROMETER; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REACTION ANALYSIS; STANDARD; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 0035499360     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.2001.5383     Document Type: Article

References (33)

1. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
2. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae
3. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver
4. A sensitive and specific stable isotope assay for warfarin and its metabolites
5. Stereochemical aspects of warfarin drug interactions: Use of a combined pharmacokinetic-pharmacodynamic model
6. Human hepatocyte growth factor down-regulates the expression of cytochrome P450 isozymes in human hepatocytes in primary culture
7. A new warfarin metabolite: Structure and function
8. Biochemical applications of a quantitative high-pressure liquid chromatographic assay of warfarin and its metabolites
9. In vitro and in vivo effects of the arylamine human immunodeficiency virusprotease inhibitor 4R-(4alpha,5alpha,6beta,7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3- [(3-aminophenyl)-methyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A
10. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9
11. Properties and stereoselectivity of carbonyl reductases involved in the ketone reduction of warfarin and analogues
12. Identification of amino acid substitutions that confer a high affinity for sulfaphenazole binding and a high catalytic efficiency for warfarin metabolism to P450 2C19
13. Correlation of human cytochrome P4502C substrate specificities with primary structure: Warfarin as a probe
14. Human P450 metabolism of warfarin
15. Chemical synthesis, absolute configuration, and stereochemistry of formation of 10-hydroxywarfarin: A major oxidative metabolite of (+)-(R)-warfarin from hepatic microsomal preparations
16. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes
17. An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes
18. Detection of 4-hydroxycoumarin anticoagulants and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography - Mass spectrometry after extractive methylation
19. Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: A 10-year follow-up
20. In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent
21. The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans
22. The rapid identification of a new metabolite of warfarin via a chemical ionization mass spectrometry ion doublet technique
23. Potential interaction between clarithromycin and warfarin
24. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: A role for P-4502C9 in the etiology of (S)-warfarin-drug interactions
25. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
26. Analysis of oxidative warfarin metabolites by thermospray high-performance liquid chromatography/mass spectrometry
27. Dissolution and ionization of warfarin
28. Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection
29. Thermospray and particle beam liquid chromatographic - Mass spectrometric analysis of coumarin anticoagulants
30. Studies on the 4-hydroxycoumarins. XVII. The resolution and absolute configuration of warfarin
31. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes
32. Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe